Research, PHARMACY MARKET

3 Pillars to Support a Winning Product Launch

January 18, 2023

3 Pillars to Support
The lifetime success of a pharmaceutical product is determined within the first few months following a product launch. Two-thirds of all product launches underperform and the majority of launches fail due to lack.

Spotlight

Pavilion Health Australia Pty Ltd.

The Pavilion Health group of companies offers an unprecedented depth of ability and experience to the health industry. As an Australian based organisation, our experience is well-founded in ICD-10-AM (International Classification of Diseases, 10th Revision, Australian Modified), ACHI (Australian Classification of Health Interventions), AR-DRG (Australian Refined Diagnosis Related Groups), and ACS (Australian Coding Standards).

OTHER WHITEPAPERS
news image

Paving the way for pharma R&D to use FAIR data

whitePaper | December 16, 2019

The use of FAIR (Findable, Accessible, Interoperable and Reusable) data in drug discovery and development could be transformational. But the pharma industry has been slow to embrace FAIR data — partially because of difficulties in establishing the necessary infrastructure and because of internal culture.

Read More
news image

Introducing EU Annex 1: Understanding the Newest Regulatory Requirements

whitePaper | July 1, 2023

As its title implies, Annex 1 is the European guidance document for good manufacturing practices of medicinal products. As such, it serves as the road map for sterile drug manufacturers to follow in order to arrive at the pathway to the highest level of sterility, assuring that their medicinal drug products deploy operational best practices, are certifiable, and regulatorily safe.

Read More
news image

Multi-channel clinical trial recruitment technology checklist

whitePaper | August 8, 2022

Biopharma R&D professionals generally admit that the current "high-cost, high-risk" development model is unsustainable. Despite technological.

Read More
news image

The convergence of the pharmaceutical and medicaldevices industries

whitePaper | May 26, 2022

The medical device and pharmaceutical industries each share in a mission to improve health outcomes, from prevention to intervention. As a result of this shared mission, integration and overlap between these two industries has been taking place for decades.

Read More
news image

Simcyp™ PBPK for Drug-Drug Interactions (DDI)

whitePaper | July 4, 2023

The past two decades have witnessed transformative changes in our approach to using modeling & simulation to assess and manage DDIs. Multidisciplinary innovations in mechanistic assessment of absorption, distribution, metabolism, and excretion (ADME), population pharmacology and pharmacogenetics.

Read More
news image

The Annual Clinical Trials Round-up 2021

whitePaper | October 13, 2022

In our previous edition of the Clinical Trials Roundup1, we explored the acute disruptions that the COVID-19 pandemic brought to the clinical trials landscape in 2020.

Read More

Spotlight

Pavilion Health Australia Pty Ltd.

The Pavilion Health group of companies offers an unprecedented depth of ability and experience to the health industry. As an Australian based organisation, our experience is well-founded in ICD-10-AM (International Classification of Diseases, 10th Revision, Australian Modified), ACHI (Australian Classification of Health Interventions), AR-DRG (Australian Refined Diagnosis Related Groups), and ACS (Australian Coding Standards).

Events